drugset / Trial / NCT02554721
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to investigate the effects of Cilostazol, Acetylsalycylic acid and Clopidogrel alone as well as combinations of Cilostazol/Acetylsalicylic acid and Cilostazol/ Clopidogrel on ex-vivo Platelet Function (PF) testing.
Timeline
- Start
- 2015-08
- Primary completion
- 2018-03-30
- Completion
- 2018-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | — |
| Subject | Cilostazol | Small molecule | 100 mg | — |
| Subject | Clopidogrel | Small molecule | 75 mg | — |
Indications
No indication recorded.